Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for XWELL, Inc. (XWEL : NSDQ)

• Company Description    XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. Number of Employees: 280

• Price / Volume Information    Yesterday's Closing Price: $1.05 Daily Weekly Monthly 20 Day Moving Average: 212,038 shares Shares Outstanding: 8.44 (millions) Market Capitalization: $8.87 (millions) Beta: 1.03 52 Week High: $2.20 52 Week Low: $0.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.96% 0.22% 12 Week -11.02% -13.45% Year To Date 127.86% 110.55%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 254 WEST 31ST STREET 11TH FLOOR - NEW YORK,NY 10001 USA ph: 212-750-9595 fax: 309-410-3967 ir@xwell.com http://www.xwell.com

• General Corporate Information    Officers Ezra T. Ernst - Chief Executive Officer and Director Ian Brown - Chief Financial Officer Bruce T. Bernstein - Director Robert Weinstein - Director Michael Lebowitz - Director Peer Information XWELL, Inc. (CHCR) XWELL, Inc. (ESRX) XWELL, Inc. (MYDP) XWELL, Inc. (COR) XWELL, Inc. (GBCS) XWELL, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 98420U802 SIC: 7200 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 8.44 Most Recent Split Date: 9.00 (0.05:1) Beta: 1.03 Market Capitalization: $8.87 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.83 Price/Cash Flow: - Price / Sales: 0.31 EPS Growth vs. Year Ago Period: -51.00% vs. Previous Quarter: 54.10% Sales Growth vs. Year Ago Period: -5.48% vs. Previous Quarter: -7.21% ROE 06/30/26 - - 03/31/26 - -2,318.99 12/31/25 - - ROA 06/30/26 - - 03/31/26 - -116.79 12/31/25 - -84.71 Current Ratio 06/30/26 - - 03/31/26 - 2.35 12/31/25 - 0.46 Quick Ratio 06/30/26 - - 03/31/26 - 2.30 12/31/25 - 0.42 Operating Margin 06/30/26 - - 03/31/26 - -81.43 12/31/25 - -58.17 Net Margin 06/30/26 - - 03/31/26 - -81.43 12/31/25 - -58.17 Pre-Tax Margin 06/30/26 - - 03/31/26 - -78.06 12/31/25 - -55.04 Book Value 06/30/26 - - 03/31/26 - 1.27 12/31/25 - -2.11 Inventory Turnover 06/30/26 - - 03/31/26 - 39.81 12/31/25 - 41.01 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - - Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - -

Powered by Zacks Investment Research ©